Daniel L. Yokell, PharmD, RPh, associate director, Radioactive Drug Regulatory Affairs in the Gordon Center for Medical Imaging and manager of PET Production Chemistry & PET Nuclear Pharmacy Services, has received the 2017 Robert E. Henkin Government Relations Fellowship from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and Education Research Foundation for Nuclear Medicine and Molecular Imaging. The fellows spend a week with SNMMI staff, visiting Congress, federal agencies and other medical societies where they learn first-hand how the federal legislative and regulatory process impacts nuclear medicine and molecular imaging. Dr. Yokell hopes to use the fellowship to enhance his knowledge of regulatory and government affairs issues to educate stakeholders on the essential role nuclear medicine and molecular imaging plays in patient care.
Nicolas Guehl was awarded the SNMMI Bradley-Alavi Student Fellowship based on his proposal “Development of methods for simultaneous rest-stress myocardial blood flow (MBF) measurements.” The fellowship is funded by the Education and Research Foundation for Nuclear Medicine and Molecular Imaging and is designed to support research activities in nuclear medicine and molecular imaging for three months. Nicolas Guehl is a research fellow at the MGH Gordon Center.
Joyita Dutta, PhD, was presented the Tracy Lynn Faber Memorial Award for her "outstanding contributions in multimodality, and molecular image reconstruction and analysis." Dr. Dutta is Assistant in Physics at the MGH Gordon Center. Dr. Dutta is Assistant in Physics at the MGH Gordon Center.
Dr. Chao Ma, Instructor at the MGH Gordon Center, was recently named Junior Fellow by the International Society for Magnetic Resonance in Medicine (ISMRM).
The award is a recognition of “outstanding researchers at an early stage in their careers.” Dr. Ma will collaborate with his ISMRM mentor for a year to further his research in ultrahigh-resolution magnetic resonance spectroscopic imaging.
Congratulations to Vasily Belov, PhD who won the First Place Poster of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for his "PET Study of Burn-Induced Tissue-Specific Insulin Resistance."His work demonstrated the primary role of impaired glucose uptake in skeletal muscles, specifically in the development of systemic insulin resistance after burn injury in a mouse model.
Congratulations to Quanzheng Li, PhD and Kyungsang Kim, PhD, who won the Low Dose CT Grand Challenge, hosted by the American Association of Physicists in Medicine (AAPM). Their algorithm achieved the best diagnostic performance on common low-dose patient CT datasets, among the participating teams from 26 countries. They presented their work and were presented the award at the annual conference of AAPM.
The Alzheimer’s Drug Discovery Foundation (ADDF) has awarded Dr. Neil Vasdev a grant to "support the development of tools to advance our understanding of Alzheimer’s disease by tracking its progression, improving patient selection for clinical trials, and monitoring patient response to drugs in trials."
Translation of an Optimized PET Radiopharmaceutical for Imaging Tau Pathology in Alzheimer's Patients
The invention of imaging agents used in positron emission tomography (PET) to detect amyloid plaques (such as the ADDF-funded Amyvid™ test) led to major breakthroughs in clinical dementia research and drug development. In such studies, radioactive drug molecules (radiopharmaceuticals) are injected and the distributions of those molecules are measured using a PET camera. A similar imaging agent for tau proteins, thought to play an important role in early Alzheimer’s disease, could lead to more breakthroughs by allowing researchers to rapidly identify novel Alzheimer’s drug treatments that engage and modify the tau proteins in the brain. Dr. Vasdev and collaborators from Merck will develop and evaluate a new tau imaging agent in clinical tests.